ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 2 - a podcast by Dr Neil Love
from 2021-12-21T17:00
::
::
Featuring perspectives from Dr Matthew Goetz, including the following topics:
- Introduction (0:00)
- Case: A woman in her late 30s with a 3-cm, weakly ER-positive, PR-negative, HER2-negative, node-positive infiltrating ductal carcinoma (IDC) — Nick C Leasure, MD (22:01)
- Case: A premenopausal woman in her late 40s with ER/PR-positive, HER2-negative, node-positive IDC — Reshma Mahtani, DO (29:59)
- Case: A woman in her late 60s with de novo ER/PR-positive, HER2-negative metastatic breast cancer (mBC) — Benjamin Parsons, DO (42:10)
- Case: A postmenopausal woman in her early 50s with de novo ER/PR-positive, HER2-negative mBC with a PIK3CA mutation — Dr Mahtani (53:50)
- SABCS 2021 Preview (57:51)
- CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love